Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
XFOR, XFOWW | X4 Pharmaceuticals, Inc | Director | $85.2K | Jun 10, 2024 | ||
SYRE | Spyre Therapeutics, Inc. | Director | Jun 22, 2023 | |||
DNTH | Dianthus Therapeutics, Inc. /DE/ | Director | May 23, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|